Clinical Trial: A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this study is to study the safety and efficacy of TAK-438, once daily (QD), in participants with a history of gastric or duodenal ulcer requiring long-term low-dose aspirin therapy will be investigated.

Detailed Summary:
Sponsor: Takeda

Current Primary Outcome: Adverse Event [ Time Frame: 24 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Takeda

Dates:
Date Received: March 29, 2012
Date Started: May 2012
Date Completion:
Last Updated: February 7, 2014
Last Verified: February 2014